US vs overseas supplement manufacturing
What you trade when you ship the formula to a cheaper plant overseas.
US vs overseas supplement manufacturing comes down to five trade-offs: unit cost, lead time, IP exposure, regulatory reach, and freight risk. HBM manufactures in Tampa Bay, FL across three facilities and 8 certifications including FDA Registration, NSF, USDA Organic, and Non-GMO Project Verified. Gummy capacity is 90,000,000 units per month at 600KG/hour across four depositors. Liquid capacity is 750,000 liters per month across 2,500L of mixing. Bench to commercial runs 8-16 weeks under one batch record chain. Overseas plants can quote lower per-unit pricing. The cost shows up later in freight, customs holds, and the inability to walk the floor.
Overseas quotes typically cover the ex-works unit price. They do not cover ocean freight, drayage, customs brokerage, FDA Prior Notice filings, or the 2-6 week sea transit. A $0.18 gummy ex-Shanghai becomes a $0.34 gummy landed in a US 3PL once freight and duties are loaded in. That math holds when the container clears on schedule. A held container changes it again.
HBM runs bench samples in 2-4 weeks, pilot batch in 2-4 weeks, and commercial production in 4-8 weeks. Total bench to first commercial pallet is 8-16 weeks. Overseas adds 4-8 weeks of ocean freight on top of the production cycle. It also adds revision cycles by email instead of by walk-through, which usually adds another round to formula sign-off.
The FDA inspects US supplement manufacturers on a routine schedule. Foreign supplement facilities are inspected at a much lower frequency. HBM is FDA-registered and audited under Florida DBPR. The cGMP record is one batch record chain, one quality system, one set of SOPs. A foreign cGMP claim is a self-declaration unless the plant is on the FDA foreign inspection list.
Every HBM project starts with an NDA before formula review. Bench, pilot, and commercial happen at the same St. Petersburg facility. Formula files do not leave the quality system. Overseas tolling can route the same formula through multiple sub-contractors. The contractual remedy for IP leakage across borders is slow and expensive.
Ocean freight from China to the US East Coast has ranged from $1,800 to $20,000 per 40-foot container in the last five years. Section 301 tariffs on supplement ingredients and finished goods can add 7.5% to 25% depending on HTS code. A stockout caused by a held container costs more in lost Amazon ranking than a year of unit-cost savings.
Overseas plants win on commodity SKUs with high volume, stable formulas, and 6-12 months of forward demand visibility. They lose on launch SKUs, reformulations, custom molds, and any program where the brand needs to be on the floor for the first commercial run. HBM does not compete on commodity pricing. HBM competes on cycle time, one-roof control, and the cert stack.
| HBM | Most contract manufacturers |
|---|---|
Frequently asked questions
Is US supplement manufacturing more expensive than overseas?
HBM's per-unit pricing is higher than a comparable overseas quote. The landed cost gap narrows once freight, duties, and tariffs are loaded in. A foreign gummy quoted at $0.18 ex-works often lands near $0.34 in a US 3PL. HBM also removes 4-8 weeks of ocean transit and the revision cycles caused by remote sign-off. The math favors US for launches and reformulations, and overseas for stable commodity SKUs.
How does FDA oversight differ for US vs overseas plants?
HBM is FDA-registered and audited under Florida DBPR. US supplement plants are inspected on a routine schedule. Foreign supplement plants are inspected far less often. A foreign cGMP claim is a self-declaration unless the plant appears on the FDA foreign inspection list. The buyer of overseas product carries the verification burden. HBM carries that burden inside its own quality system.
What are the IP risks of overseas supplement manufacturing?
Overseas tolling can route a formula through multiple sub-contractors. The contractual remedy for cross-border IP leakage is slow and expensive. HBM starts every project with an NDA before formula review. Bench, pilot, and commercial all run at the same St. Petersburg facility under one batch record chain. The formula file does not leave the HBM quality system.
How much faster is HBM than overseas manufacturing?
HBM runs bench samples in 2-4 weeks, pilot batch in 2-4 weeks, and commercial production in 4-8 weeks. Total bench to first commercial pallet is 8-16 weeks. Overseas adds 4-8 weeks of ocean freight on top of the production cycle. It also adds revision rounds because sign-off happens by email instead of on the floor. For launch SKUs, HBM is typically 2 to 4 months faster.
When does overseas supplement manufacturing still make sense?
Overseas wins on commodity SKUs with high volume, stable formulas, and 6-12 months of forward demand visibility. The unit-cost savings outweigh the freight and lead-time penalty at that profile. HBM does not compete in that lane. HBM competes on launches, reformulations, custom molds, and programs where the brand needs to be on the floor for the first commercial run.